| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Comm. &Patient Officer
1 company
Besthof Robert is a Chief Comm. &Patient Officer at NRX Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $73K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | NRXP Nrx Pharmaceuticals, Inc. | Chief Comm. &Patient Officer | Sale+OE | 40,000 | $11.76 | $470,400.00 | -62.8% | -52.4% | -93.2% |